Nifty
Sensex
:
:
23727.65
78472.87
-25.80 (-0.11%)
-67.30 (-0.09%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 540694 | NSE: Not Listed

45.40
23-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  47.00
  •  47.00
  •  44.53
  •  45.26
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  7957
  •  3.61
  •  86.06
  •  43.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 59.28
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 137.61
  • N/A
  • 0.83

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.60%
  • 0.66%
  • 25.45%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.29%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.56
  • 0.71
  • -25.57

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.88
  • -5.49
  • -31.69

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
32.89
33.26
-1.11%
18.41
56.46
-67.39%
37.84
39.44
-4.06%
18.55
46.93
-60.47%
Expenses
30.60
31.60
-3.16%
20.12
49.91
-59.69%
34.48
49.72
-30.65%
20.46
44.17
-53.68%
EBITDA
2.29
1.66
37.95%
-1.71
6.55
-
3.36
-10.28
-
-1.91
2.76
-
EBIDTM
6.96%
4.99%
-9.28%
11.60%
8.87%
-26.07%
-10.30%
5.87%
Other Income
0.35
0.22
59.09%
1.28
0.32
300.00%
0.19
9.23
-97.94%
-0.03
0.24
-
Interest
2.18
2.29
-4.80%
2.08
2.31
-9.96%
3.84
1.65
132.73%
2.51
3.47
-27.67%
Depreciation
1.74
2.22
-21.62%
1.63
2.19
-25.57%
2.05
3.03
-32.34%
1.91
2.13
-10.33%
PBT
-1.29
-2.63
-
-4.14
2.36
-
-4.08
-5.73
-
-6.37
-2.60
-
Tax
0.80
-0.31
-
-1.07
0.61
-
-0.43
-1.12
-
-0.44
-0.83
-
PAT
-2.09
-2.32
-
-3.07
1.75
-
-3.65
-4.61
-
-5.93
-1.78
-
PATM
-6.35%
-6.97%
-16.69%
3.10%
-9.64%
-11.68%
-31.97%
-3.78%
EPS
-1.60
-1.77
-
-2.35
1.34
-
-2.79
-3.53
-
-4.54
-1.36
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Net Sales
107.69
146.11
219.89
354.30
Net Sales Growth
-38.84%
-33.55%
-37.94%
 
Cost Of Goods Sold
69.77
95.12
150.59
227.98
Gross Profit
37.92
51.00
69.30
126.32
GP Margin
35.21%
34.91%
31.52%
35.65%
Total Expenditure
105.66
136.01
205.16
286.41
Power & Fuel Cost
-
4.15
6.50
6.14
% Of Sales
-
2.84%
2.96%
1.73%
Employee Cost
-
19.35
23.97
21.29
% Of Sales
-
13.24%
10.90%
6.01%
Manufacturing Exp.
-
3.53
7.19
10.04
% Of Sales
-
2.42%
3.27%
2.83%
General & Admin Exp.
-
4.01
4.10
6.16
% Of Sales
-
2.74%
1.86%
1.74%
Selling & Distn. Exp.
-
8.46
10.45
11.84
% Of Sales
-
5.79%
4.75%
3.34%
Miscellaneous Exp.
-
1.40
2.35
2.94
% Of Sales
-
0.96%
1.07%
0.83%
EBITDA
2.03
10.10
14.73
67.89
EBITDA Margin
1.89%
6.91%
6.70%
19.16%
Other Income
1.79
0.70
9.72
0.90
Interest
10.61
11.41
12.48
9.42
Depreciation
7.33
8.37
9.35
5.88
PBT
-15.88
-8.98
2.63
53.50
Tax
-1.14
-0.57
2.89
13.18
Tax Rate
7.18%
5.32%
109.89%
24.64%
PAT
-14.74
-10.14
-0.26
40.32
PAT before Minority Interest
-14.74
-10.14
-0.26
40.32
Minority Interest
0.00
0.00
0.00
0.00
PAT Margin
-13.69%
-6.94%
-0.12%
11.38%
PAT Growth
0.00%
-
-
 
EPS
-11.25
-7.74
-0.20
30.78

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Shareholder's Funds
76.28
86.22
83.77
Share Capital
13.06
13.06
10.37
Total Reserves
63.22
73.16
73.40
Non-Current Liabilities
17.13
25.04
36.69
Secured Loans
12.91
17.35
20.79
Unsecured Loans
1.04
1.14
0.84
Long Term Provisions
1.14
1.06
1.49
Current Liabilities
144.57
162.28
166.29
Trade Payables
66.18
68.19
70.63
Other Current Liabilities
23.68
31.42
29.98
Short Term Borrowings
50.33
44.93
46.58
Short Term Provisions
4.38
17.75
19.10
Total Liabilities
237.98
273.54
286.75
Net Block
58.40
88.15
92.61
Gross Block
120.52
146.86
141.97
Accumulated Depreciation
62.12
58.71
49.36
Non Current Assets
59.04
88.69
93.93
Capital Work in Progress
0.00
0.00
0.00
Non Current Investment
0.03
0.03
0.03
Long Term Loans & Adv.
0.62
0.52
0.41
Other Non Current Assets
0.00
0.00
0.88
Current Assets
173.31
183.15
192.81
Current Investments
0.00
0.00
0.00
Inventories
47.77
48.49
36.96
Sundry Debtors
73.28
83.15
102.06
Cash & Bank
5.74
6.18
6.65
Other Current Assets
46.54
1.86
1.40
Short Term Loans & Adv.
45.52
43.48
45.75
Net Current Assets
28.74
20.87
26.52
Total Assets
232.35
271.84
286.74

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Cash From Operating Activity
-9.49
26.38
24.72
PBT
-10.71
2.63
53.50
Adjustment
19.90
20.70
16.80
Changes in Working Capital
-5.27
6.51
-45.05
Cash after chg. in Working capital
3.92
29.84
25.24
Interest Paid
0.00
0.00
0.00
Tax Paid
-13.41
-3.46
-0.53
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
19.89
-9.32
-44.41
Net Fixed Assets
22.55
-4.87
Net Investments
0.00
0.00
Others
-2.66
-4.45
Cash from Financing Activity
-10.40
-17.07
19.93
Net Cash Inflow / Outflow
-0.01
-0.02
0.23
Opening Cash & Equivalents
0.32
0.35
0.11
Closing Cash & Equivalent
0.32
0.32
0.35

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Book Value (Rs.)
58.41
66.03
64.65
ROA
-3.97%
-0.09%
14.06%
ROE
-12.48%
-0.31%
48.13%
ROCE
0.46%
9.59%
39.14%
Fixed Asset Turnover
1.09
1.52
2.50
Receivable days
195.39
153.71
105.14
Inventory Days
120.23
70.92
38.08
Payable days
257.82
168.23
113.08
Cash Conversion Cycle
57.80
56.40
30.13
Total Debt/Equity
0.91
0.79
0.92
Interest Cover
0.06
1.21
6.68

Top Investors:

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.